158 related articles for article (PubMed ID: 16445618)
1. Malignant mixed müllerian tumors of the ovary: experience with cytoreductive surgery and platinum-based combination chemotherapy.
Mok JE; Kim YM; Jung MH; Kim KR; Kim DY; Kim JH; Kim YT; Nam JH
Int J Gynecol Cancer; 2006; 16(1):101-5. PubMed ID: 16445618
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for malignant mixed Müllerian tumors of the ovary.
Sit AS; Price FV; Kelley JL; Comerci JT; Kunschner AJ; Kanbour-Shakir A; Edwards RP
Gynecol Oncol; 2000 Nov; 79(2):196-200. PubMed ID: 11063643
[TBL] [Abstract][Full Text] [Related]
3. Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy.
Bicher A; Levenback C; Silva EG; Burke TW; Morris M; Gershenson DM
Obstet Gynecol; 1995 May; 85(5 Pt 1):735-9. PubMed ID: 7724104
[TBL] [Abstract][Full Text] [Related]
4. Malignant mixed müllerian tumors of the ovary: experience with surgical cytoreduction and combination chemotherapy.
Muntz HG; Jones MA; Goff BA; Fuller AF; Nikrui N; Rice LW; Tarraza HM
Cancer; 1995 Oct; 76(7):1209-13. PubMed ID: 8630899
[TBL] [Abstract][Full Text] [Related]
5. Malignant mixed mullerian tumour of the ovary: prognostic factor and response of adjuvant platinum-based chemotherapy.
Inthasorn P; Beale P; Dalrymple C; Carter J
Aust N Z J Obstet Gynaecol; 2003 Feb; 43(1):61-4. PubMed ID: 12755351
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary.
Duska LR; Garrett A; Eltabbakh GH; Oliva E; Penson R; Fuller AF
Gynecol Oncol; 2002 Jun; 85(3):459-63. PubMed ID: 12051874
[TBL] [Abstract][Full Text] [Related]
7. Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature.
Duman BB; Kara IO; Günaldi M; Ercolak V
Arch Gynecol Obstet; 2011 Jun; 283(6):1363-8. PubMed ID: 21298439
[TBL] [Abstract][Full Text] [Related]
8. Good response of malignant mixed mullerian tumor of the ovary to paclitaxel and cisplatin chemotherapy.
Eltabbakh GH; Yadav R
Eur J Gynaecol Oncol; 1999; 20(5-6):355-6. PubMed ID: 10609493
[TBL] [Abstract][Full Text] [Related]
9. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
10. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
Tangir J; Zelterman D; Ma W; Schwartz PE
Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
[TBL] [Abstract][Full Text] [Related]
11. Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus.
Wong L; See HT; Khoo-Tan HS; Low JS; Ng WT; Low JJ
Int J Gynecol Cancer; 2006; 16(3):1364-9. PubMed ID: 16803531
[TBL] [Abstract][Full Text] [Related]
12. Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy.
Nam JH; Kim YM; Jung MH; Kim KR; Yoo HJ; Kim DY; Kim JH; Kim YT; Mok JE
Int J Gynecol Cancer; 2006; 16(1):23-8. PubMed ID: 16445605
[TBL] [Abstract][Full Text] [Related]
13. Malignant mixed mullerian tumor of the ovary: report of four cases.
Melilli GA; Nappi L; Carriero C; Lapresa M; Loizzi V; Caradonna F; Quaranta M; Putignano G
Eur J Gynaecol Oncol; 2001; 22(1):67-9. PubMed ID: 11321500
[TBL] [Abstract][Full Text] [Related]
14. Malignant mixed müllerian tumor of the ovary and false negative punctures.
Cryns P; Roofthooft NJ; Tjalma WA
Eur J Gynaecol Oncol; 2003; 24(1):70-2. PubMed ID: 12691322
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival of stage IV malignant mixed Müllerian tumor of the ovary after carboplatin, mesna, ifosfamide, and cis-platin chemotherapy: case report.
Di Vagno G; Cormio G; Loverro G; Melilli GA; Di Gesù G; Selvaggi L
J Chemother; 1998 Oct; 10(5):418-21. PubMed ID: 9822362
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological spectrum of primary ovarian malignant mixed mullerian tumors (OMMMT) from a tertiary cancer institute: A series of 27 cases.
Menon S; Deodhar K; Rekhi B; Dhake R; Gupta S; Ghosh J; Maheshwari A; Mahantshetty U; Shrivastva S; Budukh A; Tongaonkar HB; Kerkar R
Indian J Pathol Microbiol; 2013; 56(4):365-71. PubMed ID: 24441223
[TBL] [Abstract][Full Text] [Related]
17. Primary malignant mixed müllerian tumor of the ovary.
Chiu SY; Twu NF; Lai CH; Yen MS; Chao KC
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):87-90. PubMed ID: 20466300
[TBL] [Abstract][Full Text] [Related]
18. Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses.
Zhang C; Li XP; Cui H; Shen DH; Wei LH
J Zhejiang Univ Sci B; 2008 Jun; 9(6):435-40. PubMed ID: 18543395
[TBL] [Abstract][Full Text] [Related]
19. Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?
Ozguroglu M; Bilici A; Ilvan S; Turna H; Atalay B; Mandel N; Sahinler I
Int J Gynecol Cancer; 2008; 18(4):809-12. PubMed ID: 17892455
[TBL] [Abstract][Full Text] [Related]
20. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
